Navigation Links
SomaLogic and New England Biolabs announce agreement to use SOMAmers for multiple PCR products
Date:7/27/2011

Boulder, CO and Ipswich, MA (July 27, 2011) SomaLogic, Inc. and New England Biolabs, Inc. (NEB) announce today that they have entered into an exclusive licensing agreement whereby SomaLogic will provide specific SOMAmers as critical and unique reagents in several current and future NEB nucleic acid amplification and polymerase chain reaction (PCR) products.

SOMAmers are specific protein binding reagents based on chemically modified "aptamers," or short single-stranded nucleic acids. Although SOMAmers have nearly unlimited potential in many different proteomic applications (e.g., biomarker discovery and validation, clinical diagnostics, drug discovery and development), NEB is incorporating specific SOMAmers into their products as reversible inhibitors of thermally active DNA polymerases used in PCR (e.g., NEB's OneTaqTM Hot Start DNA Polymerase).

"We are delighted that our colleagues at New England Biolabs see the utility of SOMAmers in enhancing and differentiating their outstanding laboratory solutions from their many competitors," said Nebojsa Janjic, Chief Science Officer of SomaLogic. "We look forward to working with them to further explore and apply the distinct advantages of our powerful technology in research laboratory settings."

"There are many opportunities to further enhance the performance of thermally active DNA polymerases in PCR reactions," states Dr. Salvatore Russello, Associate Director of Business Development at NEB. "This agreement is thus of great value to NEB, and is already being used to improve the application of DNA polymerases, such as OneTaq Hot Start."

Terms of the agreement were not disclosed.


'/>"/>

Contact: Fintan Steele, Ph.D.
fsteele@somalogic.com
SomaLogic, Inc.
Source:Eurekalert

Page: 1

Related biology news :

1. SomaLogic researchers describe revolutionary new approach to protein analysis and application to early diagnosis of lung cancer
2. Study: Illegal fishing harming present and future New England groundfish fisheries
3. Data published in the New England Journal of Medicine support use of raxibacumab (ABthrax) for the treatment of inhalation anthrax
4. LSUHSCs England plays key role in developing new ALS treatment guidelines
5. Researchers issue outlook for a significant New England red tide in 2010
6. Researchers discover potential solutions to New England roadside erosion
7. A major prize in the chemical sciences announced by the Camille and Henry Dreyfus Foundation
8. 2008 SNM Wagner-Torizuka Fellowships announced
9. NIAID announces 25 new awards to develop radiation countermeasures
10. Aware Announces Q3 2008 Earnings Conference Call
11. Governor Doyle announces historic genomic research collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/2/2016)... Feb. 2, 2016 This BCC Research ... market by reviewing the recent advances in high ... drive the field forward. Includes forecast through 2019. ... the challenges and opportunities that exist in the ... solution developers, as well as IT and bioinformatics ...
(Date:2/1/2016)... , February 1, 2016 ... advancements to drive global touchfree intuitive gesture control market ... --> Rising sales of consumer electronics coupled with ... control market size through 2020 ... electronics coupled with new technological advancements to drive global ...
(Date:1/25/2016)...   Unisys Corporation (NYSE: UIS ) today announced ... International Airport, New York City , to help ... to enter the United States using passports ... pilot testing of the system at Dulles last year. The ... during January 2016. --> pilot testing of the ...
Breaking Biology News(10 mins):
(Date:2/11/2016)... Feb. 11, 2016  Dovetail Genomics™ LLC today announced ... program for a planned metagenomic genome assembly service. ... metagenomic genome assembly method in a talk on Friday, ... & Technology conference in Orlando, Fla. ... complex datasets is difficult. Using its proprietary ...
(Date:2/11/2016)... MIAMI (PRWEB) , ... February 11, 2016 , ... ... in regenerative medicine, has announced a new agreement with Bankok,Thailand-based Global Stem Cells ... researchers and phsyicians in 15 Latin American countries, including Mexico, Costa Rica, Dominican ...
(Date:2/10/2016)... , Feb. 10, 2016  The Maryland House of ... has announced that University of Maryland School of Medicine ... and University of Maryland Medical System President and CEO ... "Speaker,s Medallion," the highest honor given to the public ... Dean Reece and Mr. Chrencik for ...
(Date:2/10/2016)... (NYSE MKT: ISR), a medical technology company and innovator ... treatment of prostate, brain, lung, head and neck and ... second quarter and six months of fiscal 2016, which ... --> Revenue was $1.19 million for ... 31, 2015, a 12% increase compared to $1.07 million ...
Breaking Biology Technology: